| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.OTOHNS.2007.02.031 |
| P698 | PubMed publication ID | 17512862 |
| P50 | author | Bradley F Marple | Q87188200 |
| P2093 | author name string | John H Krouse | |
| Stanley M Fineman | |||
| Bobby Q Lanier | |||
| Alpen A Patel | |||
| American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis | |||
| John A Fornadley | |||
| Leonard Fromer | |||
| Peter Penna | |||
| P2860 | cites work | Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study | Q25255771 |
| Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis | Q28258246 | ||
| Phenylpropanolamine and the risk of hemorrhagic stroke | Q31704504 | ||
| Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance: A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator | Q32174321 | ||
| H1-receptor antagonists: safety issues | Q33785375 | ||
| Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis | Q44448788 | ||
| Aeroallergens, allergic rhinitis, and sedating antihistamines: Risk factors for traumatic occupational injury and economic impact | Q44592002 | ||
| Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis | Q44657477 | ||
| Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis | Q45088215 | ||
| Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). | Q46377127 | ||
| Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar | Q46823812 | ||
| What are the ingredients for a successful evidence-based patient choice consultation?: A qualitative study | Q47565507 | ||
| Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis | Q47938843 | ||
| The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. | Q50567597 | ||
| Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. | Q50621222 | ||
| Comparison of the secretory response of the nasal mucosa to methacholine and histamine. | Q51663501 | ||
| Rhinitis as an independent risk factor for adult-onset asthma. | Q51723774 | ||
| Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. | Q52028496 | ||
| Informed decision making in outpatient practice: time to get back to basics. | Q52917854 | ||
| Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. | Q53461102 | ||
| Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. | Q53535114 | ||
| Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. | Q53619972 | ||
| Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials | Q33866705 | ||
| Long-term clinical efficacy of grass-pollen immunotherapy | Q33870492 | ||
| The effects of antihistamines on cognition and performance | Q33944473 | ||
| Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis | Q34083741 | ||
| Advances in H1-antihistamines | Q34368803 | ||
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| Effects of seasonal allergic rhinitis on selected cognitive abilities | Q34508581 | ||
| The burden of allergic rhinitis: beyond dollars and cents | Q34625494 | ||
| Clinical evidence for antileukotriene therapy in the management of allergic rhinitis | Q34625497 | ||
| Rethinking our approach to allergic rhinitis management | Q34625503 | ||
| Overview of comorbid associations of allergic rhinitis | Q34738178 | ||
| Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland | Q34778060 | ||
| Benefit and risk management for steroid treatment in upper airway diseases | Q34929660 | ||
| Intranasal corticosteroids for allergic rhinitis | Q34998096 | ||
| Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments | Q35071951 | ||
| Noninjection routes for immunotherapy | Q35087289 | ||
| Influences of allergic rhinitis on sleep | Q35770929 | ||
| Communicating evidence for participatory decision making | Q35776720 | ||
| Allergic rhinitis: treatment based on patient profiles | Q36401937 | ||
| Sublingual immunotherapy: a comprehensive review. | Q36468537 | ||
| Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis | Q39356899 | ||
| Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion | Q39400757 | ||
| Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis | Q39439426 | ||
| Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study | Q39581669 | ||
| Doctor-patient communication. Clinical implications of social scientific research | Q40221880 | ||
| Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis | Q40486781 | ||
| Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood | Q40488834 | ||
| Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid | Q40509154 | ||
| Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). | Q40588482 | ||
| Inhaled glucocorticoids for asthma | Q40601265 | ||
| Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial | Q40609682 | ||
| Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine | Q41661997 | ||
| Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis | Q41699385 | ||
| The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance | Q41873531 | ||
| Occupational injuries and medication use. | Q42640435 | ||
| How many teenagers think they have allergic rhinoconjunctivitis and what they do about it. | Q43488887 | ||
| Allergy in patients with acute maxillary sinusitis | Q43582835 | ||
| Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. | Q43724345 | ||
| Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall | Q44042778 | ||
| Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring | Q44051767 | ||
| Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. | Q44051945 | ||
| Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis | Q44079296 | ||
| Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology | Q44088718 | ||
| Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis | Q44365682 | ||
| P433 | issue | 6 Suppl | |
| P921 | main subject | allergic rhinitis | Q272436 |
| P304 | page(s) | S107-24 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Otolaryngology—Head and Neck Surgery | Q2646730 |
| P1476 | title | Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction | |
| P478 | volume | 136 |
| Q39811124 | A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis |
| Q89127558 | Acupuncture for moderate to severe allergic rhinitis: A non-randomized controlled trial |
| Q38070806 | Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis |
| Q37785606 | Allergic Rhinitis and Inflammatory Airway Disease: Interactions within the Unified Airspace |
| Q98386216 | Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma |
| Q34238984 | An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria |
| Q36738776 | Assessment of disease control in allergic rhinitis |
| Q37633556 | Association between allergies and risk of pancreatic cancer |
| Q37367975 | Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey |
| Q44800324 | Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis |
| Q37736669 | Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. |
| Q39185309 | Escaping the trap of allergic rhinitis. |
| Q35146166 | Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study |
| Q36311011 | High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease |
| Q93048188 | Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis |
| Q48720406 | Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters |
| Q46267822 | Management of allergic rhinitis in the era of effective over-the-counter treatments |
| Q33686509 | Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases. |
| Q46628196 | Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate |
| Q37756143 | Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older. |
| Q92635728 | Process Evaluation of the Community Pharmacist-Led Allergic Rhinitis Management (C-PhARM) Service in Singapore |
| Q38062585 | Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States. |
| Q55448056 | Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. |
| Q33773999 | Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response. |
| Q30433627 | Sneezing and runny nose: should allergy testing be routinely performed? |
| Q39246987 | The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients |
| Q110950048 | The doctor’s digital double: how warmth, competence, and animation promote adherence intention |
| Q35201033 | The international survey on the management of allergic rhinitis by physicians and patients (ISMAR). |
| Q58314867 | The patient’s hay-fever diary: three years of results from Germany |
| Q33592972 | Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease |
| Q37031239 | UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study |
Search more.